BIO-TECHNE Corp Noncash or Part Noncash Acquisition, Value of Liabilities Assumed
BIO-TECHNE Corp (TECH) reported Noncash or Part Noncash Acquisition, Value of Liabilities Assumed of $12.60 million for the 12-month period ending 2019-06-30, per its 10-K/A filed 2019-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 · last filed 2019-11-06
- BIO-TECHNE Corp noncash or part noncash acquisition, value of liabilities assumed for fiscal 2019 was $12.60M, a 802.58% increase from fiscal 2018.
- BIO-TECHNE Corp noncash or part noncash acquisition, value of liabilities assumed for fiscal 2018 was $1.40M, a 95.75% decline from fiscal 2017.
- BIO-TECHNE Corp noncash or part noncash acquisition, value of liabilities assumed for fiscal 2017 was $32.86M, a 22.25% decline from fiscal 2016.
- BIO-TECHNE Corp noncash or part noncash acquisition, value of liabilities assumed for fiscal 2016 was $42.26M, a 1.83% decline from fiscal 2015.
| Period end | Noncash or Part Noncash Acquisition, Value of Liabilities Assumed 12 month |
|---|---|
| 2019-06-30 | $12.60M 10-K/A · filed 2019-11-06 |
| 2018-06-30 | $1.40M 10-K/A · filed 2019-11-06 |
| 2017-06-30 | $32.86M 10-K/A · filed 2019-11-06 |
| 2016-06-30 | $42.26M 10-K · filed 2018-08-27 |
| 2015-06-30 | $43.05M 10-K · filed 2017-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |